About this trial
The goal of this interventional study is to evaluate the effect of multichannel functionnal electrical stimulation for subchronic stroke gait rehabilitation. The main questions it aims to answer are:
* Does this new therapy help improve walking speed? * Evaluate other aspects of therapeutic effectiveness such as different aspects of walking endurance, mobility, postural instability and autonomy. * Evaluate physiological aspects of autonomous gait such as spasticity, muscle strength and motor and sensorimotor recovery. * Evaluate the acceptability of this new therapy and its effect on quality of life.
Eligibility criteria
Qualifiers
First ischemic stroke or first hemorrhagic supratentorial stroke
Stroke must be unique
Stoke event in the last 12 months but no sooner than 6 months (post subchronic stroke phase)
Able to walk with the support of one person and one or multiple walking aids (new functionnal ambulatory classification equal to 1, 2 or 3)
Disqualifiers
Multiple strokes
Does not respond sufficiently to electrical stimulation
Contraindication to electrical stimulation
Comprehension, psychiatric or cognitive problems that could hamper the protocol
Trial design
Treatments tested in this trial
- Multichannel functionnal electrical stimulation
Treatment groups
Locations
Sponsors and collaborators
TOPMED
Lead sponsor
Kurage SAS
Collaborator
Natural Sciences and Engineering Research Council, Canada
Collaborator
Clinique Synapse - Réadaptation & Vie Active
Collaborator